New clinical studies surrounding the medication Retatrutide , specifically the 120mg formulation ZPHC ZPHC, suggest a considerable impact on weight loss and associated chronic factors. Experts believe that this innovative compound, targeting both GLP-1 and GIP systems, has the potential to offer